Search research articles
Contact Us
Filters
Showing results (141-150 of 159) with videos related to
Page
of 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 27, 2006
Colorectal cancer (CRC) screening using sigmoidoscopy followed by colonoscopy: a feasibility and efficacy study on a cancer institute based population
H Bleiberg, P Autier, F Huet, et al.
British Journal of Cancer
|
January 1, 1997
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer
C J Punt, E E Voest, E Tueni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 1997
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
H Bleiberg, T Conroy, B Paillot, et al.
Lancet (London, England)
|
November 10, 1998
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
P Rougier, E Van Cutsem, E Bajetta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2002
Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours
A Awada, F A L M Eskens, M Piccart, et al.
British Journal of Cancer
|
March 10, 2005
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study
E Van Cutsem, L Dirix, J-L Van Laethem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2000
Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): results from the European compassionate-use program
S Brienza, M A Bensmaïne, P Soulié, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2000
A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors
E Van Den Neste, D de Valeriola, J Kerger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2003
High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal Group
J Wils, G H Blijham, Th Wagener, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial
C Grimaldi, H Bleiberg, F Gay, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 159) with videos related to
Sort By:
Page
of 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 27, 2006
Colorectal cancer (CRC) screening using sigmoidoscopy followed by colonoscopy: a feasibility and efficacy study on a cancer institute based population
H Bleiberg, P Autier, F Huet, et al.
British Journal of Cancer
|
January 1, 1997
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer
C J Punt, E E Voest, E Tueni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 1997
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
H Bleiberg, T Conroy, B Paillot, et al.
Lancet (London, England)
|
November 10, 1998
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
P Rougier, E Van Cutsem, E Bajetta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2002
Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours
A Awada, F A L M Eskens, M Piccart, et al.
British Journal of Cancer
|
March 10, 2005
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study
E Van Cutsem, L Dirix, J-L Van Laethem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2000
Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): results from the European compassionate-use program
S Brienza, M A Bensmaïne, P Soulié, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2000
A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors
E Van Den Neste, D de Valeriola, J Kerger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2003
High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal Group
J Wils, G H Blijham, Th Wagener, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial
C Grimaldi, H Bleiberg, F Gay, et al.
Page
of 16